Back to top
more

MEDIFAST (MED)

(Real Time Quote from BATS)

$19.24 USD

19.24
144,225

-0.64 (-3.22%)

Updated Nov 8, 2024 03:55 PM ET

After-Market: $19.20 -0.04 (-0.21%) 4:18 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value C Growth B Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 37% (158 out of 251)

Industry: Food - Miscellaneous

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Lamb Weston (LW) Troubled by High Costs, Supply-Chain Woes

by Zacks Equity Research

Lamb Weston (LW) is battling input and transportation cost inflation along with supply-chain hiccups. The company's Retail segment is seeing tough sales comparisons with the year-ago period.

The J.M. Smucker (SJM) Hurt by High Costs, Supply-Chain Woes

by Zacks Equity Research

The J.M. Smucker (SJM) is bearing the brunt of commodity cost inflation and supply-chain volatility. Management trims earnings view during its last quarterly release.

Conagra (CAG) Troubled by Escalated Costs & Divestitures

by Zacks Equity Research

Conagra Brands (CAG) expects cost inflation of 9% in fiscal 2022. The company is also seeing tough comparisons with the year-ago period's initial pandemic-led demand spike.

McCormick (MKC) Benefits From Prudent Buyouts & Innovations

by Zacks Equity Research

McCormick (MKC) expands its presence through acquisitions to boost portfolio. The company's focus on cost savings bodes well.

Kraft Heinz's (KHC) Operating Model Solid, Costs Inflated

by Zacks Equity Research

Strength in Kraft Heinz's (KHC) operating model, which incorporates five key elements, bodes well. However, cost inflation is a persistent challenge for the company.

Zacks.com featured highlights include: Delta Apparel, Medifast and Service Corp

by Zacks Equity Research

Zacks.com featured highlights include: Delta Apparel, Medifast and Service Corp

General Mills (GIS) Poised on Key Priorities, Costs Inflated

by Zacks Equity Research

General Mills' (GIS) core priorities, focus on the Accelerate strategy and saving initiatives have been aiding the company amid an inflated cost scenario.

Why Is Medifast (MED) Down 10.8% Since Last Earnings Report?

by Zacks Equity Research

Medifast (MED) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Tirthankar Chakraborty headshot

3 of the Best Efficient Stocks to Boost Your Portfolio

by Tirthankar Chakraborty

Delta Apparel (DLA), MEDIFAST (MED) & Service Corporation International (SCI) are at present the three top efficient stocks that need to be added to your portfolio.

Altria (MO) Benefits From Low-Risk Products, High Pricing

by Zacks Equity Research

Altria (MO) is gaining from rising popularity of IQOS and on!. Strong pricing for tobacco products is also driving revenue growth.

Medifast (MED) Looks Tempting: Rallies More Than 35% in a Year

by Zacks Equity Research

Medifast (MED) has been benefiting from the strength of its OPTAVIA lifestyle solution and coaching support system as well as strategic growth endeavors like technological advancements.

Brown-Forman (BF.B) Q1 Earnings Meet Estimates, Sales Increase

by Zacks Equity Research

Brown-Forman's (BF.B) Q1 results gain from growth across geographic regions, product categories and the Travel Retail channel.

Philip Morris (PM) Gains on IQOS, Beyond Nicotine Expansion

by Zacks Equity Research

Philip Morris (PM) is gaining from rising popularity of IQOS devices. The company is also progressing with the expansion of Beyond Nicotine products that cater to medical wellness.

3 Reasons Why Growth Investors Shouldn't Overlook Medifast (MED)

by Zacks Equity Research

Medifast (MED) could produce exceptional returns because of its solid growth attributes.

Altria (MO) Hikes Dividend, Boosts Shareholders' Wealth

by Zacks Equity Research

Altria (MO) raises quarterly dividend by 4.7% to 90 cents per share. The company's new annualized dividend rate is $3.60 per share.

Hain Celestial (HAIN) Q4 Earnings Miss Estimates, Sales Down

by Zacks Equity Research

Hain Celestial's (HAIN) fourth-quarter performance reflects impacts of overlapping pandemic-led volume surge witnessed in the prior-year quarter.

The J.M. Smucker (SJM) Q1 Earnings Beat Estimates, Decline Y/Y

by Zacks Equity Research

The J.M. Smucker's (SJM) first-quarter fiscal 2022 results reflect lower earnings and sales. Results were hurt by divestiture impacts and cost inflation, which is likely to prevail.

Church & Dwight (CHD) Gains on High Demand Amid Cost Concerns

by Zacks Equity Research

Church & Dwight (CHD) has been benefiting from elevated demand amid the pandemic, including online. That said, elevated input costs and supply-chain headwinds weighed on its 2021 view.

Zacks.com featured highlights include: Deckers Outdoor, Medifast, Textron, Terex Corp and Sonos

by Zacks Equity Research

Zacks.com featured highlights include: Deckers Outdoor, Medifast, Textron, Terex Corp and Sonos

Vaishali Doshi headshot

5 Top-Ranked Liquid Stocks to Bet on for Higher Returns in 2021

by Vaishali Doshi

Here are five top-performing liquid stocks, Deckers (DECK), Medifast (MED), Textron (TXT), Terex (TEX) and Sonos (SONO), which investors can consider for healthy returns.

Is MEDIFAST INC (MED) Stock Outpacing Its Consumer Staples Peers This Year?

by Zacks Equity Research

Is (MED) Outperforming Other Consumer Staples Stocks This Year?

Mondelez (MDLZ) Teams Up With MissFresh, Fuels China Expansion

by Zacks Equity Research

Mondelez (MDLZ) teams up with MissFresh to offer Oreo Zero on the latter's popular online retail platform. This will give online customers of China access to OREO's new sugar-free sandwiches.

SpartanNash's (SPTN) Earnings Beat in Q2, Sales Decline Y/Y

by Zacks Equity Research

SpartanNash (SPTN) posts weak sales in the second quarter of 2021 due to favorable sales in the previous year on higher pandemic-led demand.

Tirthankar Chakraborty headshot

Buy 5 Top-Ranked Efficient Stocks for a Solid Portfolio

by Tirthankar Chakraborty

MEDIFAST (MED), Smith & Wesson Brands (SWBI), Encore Wire (WIRE), Cavco Industries (CVCO) & Apple (AAPL) at present flaunt solid efficiency levels and are thus believed to provide stellar returns in the near future.

Medifast (MED) Loses 13.7% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

by Zacks Equity Research

The heavy selling pressure might have exhausted for Medifast (MED) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.